Skip to main content
. 2021 Mar 29;2021:6692827. doi: 10.1155/2021/6692827

Table 2.

Characteristics of 563 febrile neutropenia episodes.

Patient characteristics Total(n = 563)
Median (range) duration of fever prior to admission (days) 1 (0, 60)
Interval since the last chemotherapy (days) (median, range) 10 (0, 148)
Therapy preceding infection, n (%)
 Induction 155 (27.5%)
 Maintenance 68 (12.1%)
Disease status, n (%)
 Remission 58 (21.7%)
 Not remission 43 (16.1%)
Duration of neutropenia (days) (median, range) 8 (1, 49)
Duration of fever in days (median, range) 3 (1, 38)
White blood cell count on admission (cells/mm³) (median, range) 670 (10, 2, 35, 150)
Absolute neutrophil count on admission (cells/mm³) (median, range) 70 (0, 9, 522)
Antifungal therapy in the past 6 months 123 (21.8%)
G-CSF use before a specific cycle 164 (29.1%)
Steroid in the past 14 days 226 (40.1%)
Central venous catheter 226 (40.1%)
 Central line 111 (19.8%)
 PICC line 102 (18.1%)
 Chemoport 10 (1.8%)
 Hickmann 3 (0.5%)